vs

Side-by-side financial comparison of Finward Bancorp (FNWD) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Finward Bancorp is the larger business by last-quarter revenue ($16.5M vs $14.7M, roughly 1.1× IRIDEX CORP). On growth, Finward Bancorp posted the faster year-over-year revenue change (1.1% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -19.1%).

Finward Bancorp is a U.S.-headquartered regional bank holding company. It offers a full range of retail and commercial banking products and services, including deposit accounts, personal and mortgage loans, small business financing, and wealth management solutions, primarily serving individual customers and small to mid-sized enterprises in its local operating regions.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

FNWD vs IRIX — Head-to-Head

Bigger by revenue
FNWD
FNWD
1.1× larger
FNWD
$16.5M
$14.7M
IRIX
Growing faster (revenue YoY)
FNWD
FNWD
+70.8% gap
FNWD
1.1%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-19.1%
FNWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FNWD
FNWD
IRIX
IRIX
Revenue
$16.5M
$14.7M
Net Profit
$2.0M
Gross Margin
37.2%
Operating Margin
11.0%
Net Margin
12.0%
Revenue YoY
1.1%
-69.7%
Net Profit YoY
-5.6%
EPS (diluted)
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FNWD
FNWD
IRIX
IRIX
Q4 25
$16.5M
$14.7M
Q3 25
$17.4M
$12.5M
Q2 25
$16.6M
$13.6M
Q1 25
$15.5M
$11.9M
Q4 24
$16.3M
$12.7M
Q3 24
$14.9M
$11.6M
Q2 24
$14.6M
$12.6M
Q1 24
$25.3M
$11.8M
Net Profit
FNWD
FNWD
IRIX
IRIX
Q4 25
$2.0M
Q3 25
$3.5M
$-1.6M
Q2 25
$2.2M
$-994.0K
Q1 25
$455.0K
$-1.7M
Q4 24
$2.1M
$-834.0K
Q3 24
$606.0K
$-1.9M
Q2 24
$143.0K
$-2.7M
Q1 24
$9.3M
$-3.5M
Gross Margin
FNWD
FNWD
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
FNWD
FNWD
IRIX
IRIX
Q4 25
11.0%
Q3 25
20.5%
-11.3%
Q2 25
12.7%
-6.9%
Q1 25
4.0%
-1.7%
Q4 24
16.3%
-3.9%
Q3 24
2.7%
-16.1%
Q2 24
0.9%
-20.9%
Q1 24
40.6%
-28.0%
Net Margin
FNWD
FNWD
IRIX
IRIX
Q4 25
12.0%
Q3 25
20.1%
-12.6%
Q2 25
12.9%
-7.3%
Q1 25
2.9%
-14.2%
Q4 24
12.9%
-6.6%
Q3 24
4.1%
-16.7%
Q2 24
1.0%
-21.2%
Q1 24
36.7%
-29.5%
EPS (diluted)
FNWD
FNWD
IRIX
IRIX
Q4 25
$0.46
Q3 25
$0.81
$-0.09
Q2 25
$0.50
$-0.06
Q1 25
$0.11
$-0.10
Q4 24
$0.50
$-0.05
Q3 24
$0.14
$-0.12
Q2 24
$0.03
$-0.16
Q1 24
$2.17
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FNWD
FNWD
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$174.7M
Total Assets
$2.0B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FNWD
FNWD
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
FNWD
FNWD
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
FNWD
FNWD
IRIX
IRIX
Q4 25
$174.7M
Q3 25
$165.5M
$4.7M
Q2 25
$154.3M
$6.1M
Q1 25
$151.8M
$852.0K
Q4 24
$151.4M
$2.1M
Q3 24
$159.6M
$2.6M
Q2 24
$148.6M
$4.2M
Q1 24
$151.6M
$6.5M
Total Assets
FNWD
FNWD
IRIX
IRIX
Q4 25
$2.0B
$29.2M
Q3 25
$2.1B
$28.4M
Q2 25
$2.1B
$31.6M
Q1 25
$2.0B
$34.2M
Q4 24
$2.1B
$29.1M
Q3 24
$2.1B
$30.2M
Q2 24
$2.1B
$31.2M
Q1 24
$2.1B
$34.1M
Debt / Equity
FNWD
FNWD
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FNWD
FNWD
IRIX
IRIX
Operating Cash FlowLast quarter
$9.9M
Free Cash FlowOCF − Capex
$9.0M
FCF MarginFCF / Revenue
54.8%
Capex IntensityCapex / Revenue
5.2%
Cash ConversionOCF / Net Profit
4.99×
TTM Free Cash FlowTrailing 4 quarters
$10.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FNWD
FNWD
IRIX
IRIX
Q4 25
$9.9M
Q3 25
$1.2M
$-1.2M
Q2 25
$4.8M
$-397.0K
Q1 25
$-3.8M
$-1.1M
Q4 24
$9.8M
$-1.2M
Q3 24
$-3.7M
$-3.1M
Q2 24
$2.8M
$-1.3M
Q1 24
$-25.0K
$-1.6M
Free Cash Flow
FNWD
FNWD
IRIX
IRIX
Q4 25
$9.0M
Q3 25
$1.0M
$-1.2M
Q2 25
$4.5M
$-410.0K
Q1 25
$-4.0M
$-1.2M
Q4 24
$6.7M
$-1.2M
Q3 24
$-4.2M
$-3.1M
Q2 24
$1.1M
Q1 24
$-736.0K
$-1.7M
FCF Margin
FNWD
FNWD
IRIX
IRIX
Q4 25
54.8%
Q3 25
6.0%
-9.4%
Q2 25
27.0%
-3.0%
Q1 25
-25.7%
-9.8%
Q4 24
41.2%
-9.8%
Q3 24
-28.5%
-26.5%
Q2 24
7.6%
Q1 24
-2.9%
-14.0%
Capex Intensity
FNWD
FNWD
IRIX
IRIX
Q4 25
5.2%
Q3 25
0.9%
0.1%
Q2 25
1.7%
0.1%
Q1 25
1.2%
0.1%
Q4 24
18.8%
0.1%
Q3 24
3.4%
0.0%
Q2 24
11.2%
0.0%
Q1 24
2.8%
0.0%
Cash Conversion
FNWD
FNWD
IRIX
IRIX
Q4 25
4.99×
Q3 25
0.34×
Q2 25
2.22×
Q1 25
-8.37×
Q4 24
4.66×
Q3 24
-6.15×
Q2 24
19.23×
Q1 24
-0.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons